Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Feb. 10, 2021
Aug. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Proceeds from exercise of warrants     $ 707
Number of shares exercised    
Preferred stock, authorized     5,000,000 5,000,000
Treasury stock, shares     17,477 17,477
Treasury stock at cost     $ 40 $ 40
Maximum [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Preferred stock, authorized     5,000,000  
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Aggregate grant date fair value     $ 515  
Stock-based compensation expense     $ 515  
Common Stock [Member] | Underwritten Public Offering [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued in transaction 750,000      
Offering net proceeds $ 12,466      
Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Warrant to purchase shares of common stock       225,878
Proceeds from exercise of warrants       $ 707
Number of shares exercised       120,000
Stock issued during the period, cashless exercise option       61,644
Officers Employees and Consultants [Member] | Employee Retention Program [Member] | 2016 Omnibus Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of shares issued   161,347